Altered systemic ketone body metabolism in advanced heart failure

Texas Heart Institute Journal

Volumn 38, Issue 5, 2011, Pages 533-538

  Janardhan, Ajit ^a   Chen, Jane ^a   Crawford, Peter A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Energy metabolism; Exercise tolerance physiology; Heart diseases metabolism; Heart failure blood physiopathology; Heart physiopathology; Ketone bodies blood metabolism; Muscle; Skeletal blood

Indexed keywords

CREATININE; FATTY ACID; GLUCOSE; KETONE BODY; NITROGEN; UREA;

ADULT; ADVANCED HEART FAILURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; CREATININE BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE; HUMAN; KETONE BODY METABOLISM; MALE; METABOLITE; SKELETAL MUSCLE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; KETONE BODIES; MALE; MIDDLE AGED; MISSOURI; MUSCLE FATIGUE; MUSCLE, SKELETAL; MYOCARDIUM; SEVERITY OF ILLNESS INDEX;

EID: 83455179322     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bing RJ. The metabolism of the heart. Harvey Lect 1954-1955;50:27-70.
2. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Bio-chem J 1980;186(3):701-11.
3. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010;90(1):207-58.
4. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigorito C, et al. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 1990;258(4 Pt 1):E606-18.
5. Taegtmeyer H, McNulty P, Young ME. Adaptation and mal- adaptation of the heart in diabetes: Part I: general concepts. Circulation 2002;105(14):1727-33.
6. Young ME, McNulty P, Taegtmeyer H. Adaptation and mal-adaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002;105(15):1861-70.
7. Davila-Roman VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomy-opathy. J Am Coll Cardiol 2002;40(2):271-7.
8. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 2004;95(2):135-45.
9. Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007;293(6):H3270-8.
10. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation 2007;116(4):434-48.
11. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 2008;51(2):93-102.
12. Gropler RJ. Lost in translation: modulation of the metabolic-functional relation in the diabetic human heart. Circulation 2009;119(15):2020-2.
13. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007;356(11):1140-51.
14. Wilson JR, Fink L, Maris J, Ferraro N, Power-Vanwart J, Eleff S, Chance B. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985;71(1):57-62.
15. Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85(5):1751-9.
16. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85(4):1364-73.
17. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 2010;3(4):537-46.
18. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004;70(3):309-19.
19. Rudolph W, Maas D, Richter J, Hasinger F, Hofmann H, Dohrn P. On the significance of acetoacetate and beta-hydroxybutyrate in human myocardial metabolism [in German]. Klin Wochenschr 1965;43:445-51.
20. Williamson JR. Mitochondrial function in the heart. Annu Rev Physiol 1979;41:485-506.
21. Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 1980;60(1):143-87.
22. Russell RR 3rd, Taegtmeyer H. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. J Clin Invest 1991;87(2):384-90.
23. Sultan AM. Effects of diabetes and insulin on ketone bodies metabolism in heart. Mol Cell Biochem 1992;110(1):17-23.
24. Jeffrey FM, Diczku V, Sherry AD, Malloy CR. Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic Res Cardiol 1995;90(5): 388-96.
25. Lommi J, Kupari M, Koskinen P, Naveri H, Leinonen H, Pulkki K, Harkonen M. Blood ketone bodies in congestive heart failure. J Am Coll Cardiol 1996;28(3):665-72.
26. Rudolph W, Schinz A. Studies on myocardial blood f low, oxygen consumption, and myocardial metabolism in patients with cardiomyopathy. Recent Adv Stud Cardiac Struct Metab 1973;2:739-49.
27. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 1995;9(8):651-8.
28. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 2004;70(3): 243-51.
29. Cotter DG, d'Avignon DA, Wentz AE, Weber ML, Crawford PA. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J Biol Chem 2011;286(9):6902-10.
30. Tildon JT, Cornblath M. Succinyl-CoA: 3-ketoacid CoA transferase deficiency. A cause for ketoacidosis in infancy. J Clin Invest 1972;51(3):493-8.
31. Best TH, Franz DN, Gilbert DL, Nelson DP, Epstein MR. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000;54(12):2328-30.
32. Trinity JD, Richardson RS. Integrative research: the key to unlocking the mysteries of chronic heart failure and skeletal muscle dysfunction. Am J Physiol Heart Circ Physiol 2010; 299(6):H1750-2.
33. Van Berendoncks AM, Conraads VM. Functional adiponectin resistance and exercise intolerance in heart failure. Curr Heart Fail Rep 2011;8(2):113-22.
34. Marazzi G, Rosanio S, Caminiti G, Dioguardi FS, Mercuro G. The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure. Curr Pharm Des 2008;14(25):2592-604.
35. Sun H, Lu G, Ren S, Chen J, Wang Y. Catabolism of branched-chain amino acids in heart failure: insights from genetic models. Pediatr Cardiol 2011;32(3):305-10.
36. Marinou K, Adiels M, Hodson L, Frayn KN, Karpe F, Fielding BA. Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, com- pared with young men. Br J Nutr 2011;105(6):857-65.
37. Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 2007;14(4):573-81.
38. Nair KS. Aging muscle. Am J Clin Nutr 2005;81(5):953-63.
39. Soto PF, Herrero P, Kates AM, Dence CS, Ehsani AA, Davila-Roman V, et al. Impact of aging on myocardial metabolic response to dobutamine. Am J Physiol Heart Circ Physiol 2003;285(5):H2158-64.
40. Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner. J Anesth 2005;19(4):277-81.
41. Nishiyama T, Yokoyama T, Hanaoka K. Effects of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver function. Acta Anaesthesiol Scand 1999;43(3):347-51.